Heparin inhibits IP3-induced Ca2+ release in permeabilized pancreatic β-cells  by Nilsson, Thomas et al.
Volume 229, number 1,211-214 FEB 05640 February 1988 
Heparin inhibits IP3-induced Ca 2+ release in permeabilized 
pancreatic fl-cells 
Thomas  Nilsson, Jean Zwil ler +, A l ton L. Boynton  + and Per -O lo f  Berggren 
Department of Medical Cell Biology, University of Uppsala, Biomedicum, Box 571, S-751 23 Uppsala, Sweden and 
+Cancer Research Center of Hawaii, 1236 Lauhala St., Honolulu, Hawaii 96813, USA 
Received 15 January 1988 
Heparin was found to inhibit he Ca 2+ release induced by inositoi 1,4,5-trisphosphate (IP3) in permeabilized pancreatic 
fit:ells obtained from obese hyperglycemic ice. The effect of heparin was dose-dependent a dnot due to inhibition of 
Ca 2+ uptake into the IP3-sensitive pool. The effect appeared specific for hepafin and was not reproduced byother polysac- 
charides uch as chondroitin sulfates. Heparin might consequently bea useful tool when investigating the molecular 
mechanism whereby IP3 mobilizes Ca 2+ .
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1. INTRODUCTION 
In a variety of cells certain agonists activate 
phospholipase C, promoting the hydrolysis of in- 
ositol 4,5-bisphosphate with the subsequent for- 
mation of diacylglycerol and inositol 1,4,5-tris- 
phosphate (IP3) [1]. Whereas diacylglycerol is an 
activator of protein kinase C, IP3 releases Ca 2+ 
f rom intracellular stores [1]. The target for IP3 is 
most likely the endoplasmic reticulum [1], 
although it has recently been proposed that the 
trisphosphate-sensitive pool represents a morpho- 
logically distinct organelle [2]. The IP3-induced 
Ca 2+ release is well characterized in many different 
cell types, but so far the underlying mechanism is
unknown. The trisphosphate is believed to activate 
a membrane bound receptor egulating the open- 
ing of  some sort of Ca 2+ channel [3]. Specific 
binding sites for IP3 have been described in many 
tissues [4-6], but little is known about the nature 
of the putative Ca 2+ channel. After having fulfilled 
its role as second messenger, IP3 can either be step- 
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wise dephosphorylated or converted to inositol 
1,3,4,5-tetrakisphosphate (IP4) by a specific ino- 
sitol 1,4,5-trisphosphate kinase [7-10]. Although 
the physiological role of IP4 is somewhat unclear, 
it has been suggested that it opens up channels for 
Ca 2+ in the plasma membrane [11]. 
Recently two of us discovered that IP3 and IP4 
activate a protein phosphatase isolated from rat 
brain (Zwiller and Boynton, unpublished). This 
enzyme was active in the absence of metal ions, 
preferentially membrane bound and inhibited by 
heparin, indicating that it may correspond to a 
protein phosphatase type-I [12]. Such an enzyme 
might consequently be involved in the mechanism 
whereby IP3 releases Ca 2+. In the present study, we 
decided to investigate whether heparin interferes 
with IP3-induced Ca 2+ release in permeabilized 
pancreatic B-cells. 
2. MATERIALS AND METHODS 
Pancreatic islets were obtained from obese hyperglycemic 
mice (ob/ob) taken from a local non-inbred colony [13]. A if- 
cell suspension was prepared and cultured as described [14]. 
The cells were permeabilized with electrical discharges (5 x 2.5 
kV/cm) and suspended in 25 #1 medium containing 110 mM 
KCI, 10 mM NaC1, 2 mM KH2PO4, 1 mM MgCI2, 2 mM 
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MgATP, 10 mM phosphocreatine, 20 U/ml creatine 
phosphokinase, 0.2 ~M antimycin and 1 ~g/ml oligomycin 
[15,16]. pH was 7.0 and the ambient Ca 2+ concentration was 
monitored with a Ca 2+ selective electrode [17]. Test substances 
were added as 100 x concentrated stock solutions with con- 
stant volume pipettes [18]. All experiments were performed 
with magnetic stirring at room temperature. The traces hown 
are typical for experiments repeated with at least hree different 
cell preparations. Heparin, chondroitin sulfate A and C were 
bought from Sigma. IP3 was from Amersham and IP4 was a gift 
from Dr R.F. Irvine, Cambridge, England. 
3. RESULTS AND DISCUSSION 
When electrically permeabilized pancreatic /3- 
cells were incubated in a Ca2+-deficient medium 
containing ATP, an ATP regenerating system and 
mitochondrial inhibitors, there was a marked se- 
questration of Ca 2+ (fig. 1A), most likely promoted 
by the endoplasmic reticulum [19]. Under these 
conditions, addition of IP3 evoked a pronounced 
mobilization of Ca 2+. In fig.lB the cells were in- 
cubated in the presence of 50 /~g/ml heparin. 
Whereas there was almost no response to IP3, a 
pulse addition of Ca 2+ still elicited a transient rise 
in the ambient Ca 2+ concentration. This effect of 
heparin could not be explained in terms of an in- 
hibition of Ca 2+ uptake into the IPrsensit ive pool, 
since heparin added just prior to IP3 produced the 
same effect (fig.lC). As demonstrated in fig.2, the 
effect of  heparin was dose-dependent. Stimulation 
of Ca 2+ release with 6 /zM IP3 was slightly at- 
tenuated by 1/~g/ml heparin and completely in- 
hibited at 100/zg/ml. Approx. 5-10/zg/ml heparin 
caused a 50% inhibition of the IP3-induced Ca 2+ 
release. Previous studies have shown that the ac- 
tivity of protein phosphatase-!, isolated from rab- 
bit skeletal muscle and liver, is inhibited by heparin 
at concentrations similar to those used in the pre- 
sent study, but not by chondroitin sulfate A and C 
[20,21]. In accordance with these results, neither 
chondroitin sulfate A (fig.3A) nor C (not shown) 
had any effect, even at concentrations as high as 
100/~g/ml. Since the stimulatory effect of IP3 on 
the phosphatase activity was inhibited by Mg 2+ 
(Zwiller and Boynton, unpublished), we in- 
vestigated the trisphosphate-induced Ca 2+ release 
in the presence of high concentrations of this 
divalent cation. However, as is shown in fig.3B, 10 
mM Mg 2+ neither inhibited the Ca 2+ release pro- 
moted by IP3 nor interfered with the effect of 
heparin (not shown). Although IP4 was found to 
activate the phosphatase, 10 /~M of the 
tetrakisphosphate was ineffective in releasing Ca 2+ 
in permeabilized B-cells, as has previously been 
reported for other ceil types, including insulin pro- 
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Fig. 1. Effects of 6/~M IP3, 50 ~g/ml heparin and 0.25 nmol Ca 2+ on the ambient Ca 2+ concentration maintained by permeabilized 
pancreatic ~'-cells. In C, 50/~g/ml heparin was present throughout the experiment. 
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Fig.2. Effect of increasing concentrations of heparin on Ca 2+ 
release induced by 6/zM IP3. Mean + SE for 3-7 experiments. 
ducing RINm5F cells [10,22,23]. It is therefore not 
likely, at least in pancreatic d-cells, that IP3 pro- 
motes Ca 2+ release by activating a protein 
phosphatase. 
When looking for possible inhibitors of the 
IP3-induced Ca 2+ release, it is of interest o note 
that monoclonal antibodies, which effectively in- 
hibit the action of IP3 on platelet membranes, have 
been produced [24]. Morever, the IPrinduced 
Ca 2+ release has been found to be suppressed by 
micromolar concentrations of Cd 2+ in permeabil- 
ized d-cells [15]. The effect of Cd 2+ might reflect 
its binding to IP3 and thereby changing the binding 
properties of the trisphosphate o its receptor [25]. 
We cannot exclude that heparin also exerts its ef- 
fect by binding IP3, but it should be remembered 
that both the polysaccaride and the trisphosphate 
are negatively charged [26]. Recently it was 
demonstrated that heparin interacts with receptors 
for IP3 in cerebellar membranes [27]. It is possible 
that such a mechanism also operates in pancreatic 
#-cells. 
Heparin is known to interact, not only with pro- 
tein phosphatases, but with a variety of different 
proteins [26,28,29]. The effect of heparin on the 
IPrinduced Ca 2+ release is probably of unspecific 
nature and most likely of no physiological 
relevance. However, by using heparin and/or 
fragments of this polysaccharide, it should be 
possible to clarify more specifically the molecular 
identity of the inhibitory site and thereby get a bet- 
ter understanding of the intricate mechanism 
whereby IP3 promotes Ca 2+ release. 
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Fig.3. Effects of 6/zM IP3 and 10/~M IP4 on the ambient Ca 2+ concentration maintained by permeabilized #-cells. In A and B, the 
incubations were performed in the presence of 100/~g/ml chondroitin sulfate A and 10 mM MgCI2, respectively. 
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